{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T05:22:59Z","timestamp":1793856179868,"version":"4.6.1"},"reference-count":139,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T00:00:00Z","timestamp":1782777600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T00:00:00Z","timestamp":1782777600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"National Research Centre Egypt"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Discover Nano"],"DOI":"10.1186\/s11671-026-04702-7","type":"journal-article","created":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T22:16:08Z","timestamp":1782857768000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Lipid nanocarriers as innovative strategies for hair regrowth"],"prefix":"10.1186","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1017-527X","authenticated-orcid":false,"given":"Rabab","family":"Kamel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shimaa K.","family":"Mohamed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mona M.","family":"AbouSamra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,30]]},"reference":[{"issue":"4","key":"4702_CR1","doi-asserted-by":"publisher","first-page":"93","DOI":"10.15406\/jdc.2021.05.00190","volume":"5","author":"H Rambwawasvika","year":"2021","unstructured":"Rambwawasvika H, Dzomba P, Gwatidzo L. Alopecia types, current and future treatment. J Dermatol Cosmetol. 2021;5(4):93\u20139.","journal-title":"J Dermatol Cosmetol"},{"issue":"2","key":"4702_CR2","doi-asserted-by":"publisher","first-page":"123","DOI":"10.52711\/2231-5691.2023.00025","volume":"13","author":"PC Rahangdale","year":"2023","unstructured":"Rahangdale PC, Wankhade AM. A review on-types and treatment of alopecia. Asian J Pharm Res. 2023;13(2):123\u20138.","journal-title":"Asian J Pharm Res"},{"issue":"3","key":"4702_CR3","doi-asserted-by":"publisher","first-page":"R132","DOI":"10.1016\/j.cub.2008.12.005","volume":"19","author":"MR Schneider","year":"2009","unstructured":"Schneider MR, Schmidt-Ullrich R, Paus R. The hair follicle as a dynamic miniorgan. Curr Biol. 2009;19(3):R132\u201342.","journal-title":"Curr Biol"},{"key":"4702_CR4","unstructured":"Noreen S, Pervaiz F, Maqbool I, Saleem M. Alopecia: review of epidemiology, pathogenesis, and novel treatment strategies."},{"issue":"4","key":"4702_CR5","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1159\/000506155","volume":"236","author":"KS Houschyar","year":"2020","unstructured":"Houschyar KS, Borrelli MR, Tapking C, Popp D, Puladi B, Ooms M, et al. Molecular mechanisms of hair growth and regeneration: current understanding and novel paradigms. Dermatology. 2020;236(4):271\u201380.","journal-title":"Dermatology"},{"key":"4702_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.jddst.2024.105890","author":"TD Khairnar","year":"2024","unstructured":"Khairnar TD, Chavan GS, Sayyed MM, Gujarathi NA, Aher AA, Agrawal YO, et al. Recent trends in nanocarrier formulations of actives beyond minoxidil and 5-\u03b1 reductase inhibitors in androgenetic alopecia management: a systematic review. J Drug Deliv Sci Technol. 2024. https:\/\/doi.org\/10.1016\/j.jddst.2024.105890.","journal-title":"J Drug Deliv Sci Technol"},{"key":"4702_CR7","first-page":"100305","volume":"8","author":"AS Alfutaimani","year":"2024","unstructured":"Alfutaimani AS, Alharbi NK, Alahmari SA, Alqabbani AA, Aldayel AM. Exploring the landscape of lipid nanoparticles (LNPs): a comprehensive review of LNPs types and biological sources of lipids. Int J Pharm X. 2024;8:100305.","journal-title":"Int J Pharm X"},{"key":"4702_CR8","doi-asserted-by":"publisher","first-page":"485","DOI":"10.2147\/CCID.S284435","volume":"14","author":"CO Cardoso","year":"2021","unstructured":"Cardoso CO, Tolentino S, Gratieri T, Cunha-Filho M, Lopez RF, Gelfuso GM. Topical treatment for scarring and non-scarring alopecia: an overview of the current evidence. Clin Cosmet Investig Dermatol. 2021;14:485\u201399.","journal-title":"Clin Cosmet Investig Dermatol"},{"issue":"3","key":"4702_CR9","doi-asserted-by":"publisher","first-page":"243","DOI":"10.5021\/ad.2012.24.3.243","volume":"24","author":"W-S Lee","year":"2012","unstructured":"Lee W-S, Lee H-J. Characteristics of androgenetic alopecia in Asian. Ann Dermatol. 2012;24(3):243.","journal-title":"Ann Dermatol"},{"issue":"2","key":"4702_CR10","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.autrev.2014.10.014","volume":"14","author":"N Islam","year":"2015","unstructured":"Islam N, Leung PS, Huntley AC, Gershwin ME. The autoimmune basis of alopecia areata: a comprehensive review. Autoimmun Rev. 2015;14(2):81\u20139.","journal-title":"Autoimmun Rev"},{"key":"4702_CR11","doi-asserted-by":"publisher","first-page":"107","DOI":"10.2147\/CCID.S22767","volume":"4","author":"A Alsantali","year":"2011","unstructured":"Alsantali A. Alopecia areata: a new treatment plan. Clin Cosmet Investig Dermatol. 2011;4:107\u201315.","journal-title":"Clin Cosmet Investig Dermatol"},{"issue":"3","key":"4702_CR12","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.7314\/APJCP.2015.16.3.1225","volume":"16","author":"K Ishida","year":"2015","unstructured":"Ishida K, Ishida J, Kiyoko K. Psychosocial reaction patterns to alopecia in female patients with gynecological cancer undergoing chemotherapy. Asian Pac J Cancer Prev. 2015;16(3):1225\u201333.","journal-title":"Asian Pac J Cancer Prev"},{"issue":"2","key":"4702_CR13","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.jgr.2015.07.004","volume":"40","author":"DI Keum","year":"2016","unstructured":"Keum DI, Pi L-Q, Hwang ST, Lee W-S. Protective effect of Korean Red Ginseng against chemotherapeutic drug-induced premature catagen development assessed with human hair follicle organ culture model. J Ginseng Res. 2016;40(2):169\u201375.","journal-title":"J Ginseng Res"},{"issue":"1","key":"4702_CR14","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.jdcr.2019.08.010","volume":"6","author":"MH Ghias","year":"2020","unstructured":"Ghias MH, Amin BD, Kutner AJ. Albendazole-induced anagen effluvium. JAAD Case Rep. 2020;6(1):54\u20136.","journal-title":"JAAD Case Rep"},{"issue":"2","key":"4702_CR15","first-page":"427","volume":"61","author":"L Castelo-Soccio","year":"2014","unstructured":"Castelo-Soccio L. Diagnosis and management of alopecia in children. Pediatr Clin. 2014;61(2):427\u201342.","journal-title":"Pediatr Clin"},{"issue":"3","key":"4702_CR16","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1159\/000369405","volume":"47","author":"R Alves","year":"2015","unstructured":"Alves R, Grimalt R. Hair loss in children. Curr Probl Dermatol. 2015;47(3):55\u201366.","journal-title":"Curr Probl Dermatol"},{"issue":"9","key":"4702_CR17","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1176\/appi.ajp.2016.15111432","volume":"173","author":"JE Grant","year":"2016","unstructured":"Grant JE, Chamberlain SR. Trichotillomania. Am J Psychiatry. 2016;173(9):868\u201374.","journal-title":"Am J Psychiatry"},{"key":"4702_CR18","doi-asserted-by":"publisher","DOI":"10.2147\/ccid.s137296","author":"V Billero","year":"2018","unstructured":"Billero V, Miteva M. Traction alopecia: The root of the problem. Clin Cosmet Investig Dermatol. 2018. https:\/\/doi.org\/10.2147\/ccid.s137296.","journal-title":"Clin Cosmet Investig Dermatol"},{"issue":"12","key":"4702_CR19","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.1111\/ijd.12707","volume":"54","author":"H Mesrati","year":"2015","unstructured":"Mesrati H, Amouri M, Chaaben H, Masmoudi A, Boudaya S, Turki H. Aplasia cutis congenita: report of 22 cases. Int J Dermatol. 2015;54(12):1370\u20135.","journal-title":"Int J Dermatol"},{"issue":"1","key":"4702_CR20","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1080\/09168451.2018.1518705","volume":"83","author":"M Maekawa","year":"2019","unstructured":"Maekawa M, Ohnishi T, Balan S, Hisano Y, Nozaki Y, Ohba H, et al. Thiosulfate promotes hair growth in mouse model. Biosci Biotechnol Biochem. 2019;83(1):114\u201322.","journal-title":"Biosci Biotechnol Biochem"},{"key":"4702_CR21","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1007\/s40257-025-00990-4","volume":"27","author":"MM Ong","year":"2025","unstructured":"Ong MM, Li Y, Lipner SR. Oral Minoxidil for alopecia treatment: risks, benefits, and recommendations. Am J Clin Dermatol. 2025;27:101\u201319.","journal-title":"Am J Clin Dermatol"},{"key":"4702_CR22","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1007\/s40265-016-0629-5","volume":"76","author":"Y Kelly","year":"2016","unstructured":"Kelly Y, Blanco A, Tosti A. Androgenetic alopecia: an update of treatment options. Drugs. 2016;76:1349\u201364.","journal-title":"Drugs"},{"key":"4702_CR23","doi-asserted-by":"publisher","first-page":"16311","DOI":"10.1007\/s00210-025-04286-6","volume":"398","author":"AT Allam","year":"2025","unstructured":"Allam AT, El-Shiekh RA, El-Dessouki AM, Gamil NM, Eisa NM, Ayoub MM, et al. Pathophysiology, conventional treatments, and evidence-based herbal remedies of hair loss with a systematic review of controlled clinical trials. Naunyn-Schmiedeberg\u2019s Arch Pharmacol. 2025;398:16311\u201344.","journal-title":"Naunyn-Schmiedeberg\u2019s Arch Pharmacol"},{"issue":"8","key":"4702_CR24","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1007\/s40265-023-01880-x","volume":"83","author":"S Devjani","year":"2023","unstructured":"Devjani S, Ezemma O, Kelley KJ, Stratton E, Senna M. Androgenetic alopecia: therapy update. Drugs. 2023;83(8):701\u201315.","journal-title":"Drugs"},{"issue":"9","key":"4702_CR25","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1007\/s40265-023-01873-w","volume":"83","author":"E Freitas","year":"2023","unstructured":"Freitas E, Guttman-Yassky E, Torres T. Baricitinib for the treatment of alopecia areata. Drugs. 2023;83(9):761\u201370.","journal-title":"Drugs"},{"issue":"4","key":"4702_CR26","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1111\/1346-8138.17641","volume":"52","author":"M Wada\u2010Irimada","year":"2025","unstructured":"Wada\u2010Irimada M, Takahashi T, Sekine M, Okazaki T, Takahashi T, Chiba T, et al. Predictive factors for treatment responses to baricitinib in severe alopecia areata: a retrospective, multivariate analysis of 70 cases from a single center. J Dermatol. 2025;52(4):701\u201311.","journal-title":"J Dermatol"},{"issue":"9","key":"4702_CR27","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1007\/s40267-024-01086-5","volume":"40","author":"M Shirley","year":"2024","unstructured":"Shirley M. Ritlecitinib in severe alopecia areata: a profile of its use. Drugs Ther Perspect. 2024;40(9):341\u20139.","journal-title":"Drugs Ther Perspect"},{"issue":"2","key":"4702_CR28","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1016\/j.jaad.2024.09.064","volume":"92","author":"M Piliang","year":"2025","unstructured":"Piliang M, Lynde C, King B, Mirmirani P, Sinclair R, Senna M, et al. Sustained hair regrowth with continued ritlecitinib treatment through week 48 in patients with Alopecia Areata with or without early target responses: post hoc analysis of the ALLEGRO phase 2b\/3 trial. J Am Acad Dermatol. 2025;92(2):276\u201384.","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"4702_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.35702\/clinres.10023","volume":"5","author":"T Javed","year":"2024","unstructured":"Javed T. FDA approval of Deuruxolitinib: a new treatment option for severe Alopecia Areata. Clin Res. 2024;5(1):1\u20133.","journal-title":"Clin Res"},{"issue":"5","key":"4702_CR30","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1016\/j.jaad.2024.06.097","volume":"91","author":"B King","year":"2024","unstructured":"King B, Senna MM, Mesinkovska NA, Lynde C, Zirwas M, Maari C, et al. Efficacy and safety of deuruxolitinib, an oral selective Janus kinase inhibitor, in adults with alopecia areata: results from the Phase 3 randomized, controlled trial (THRIVE-AA1). J Am Acad Dermatol. 2024;91(5):880\u20138.","journal-title":"J Am Acad Dermatol"},{"key":"4702_CR31","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1007\/s00403-019-02003-x","volume":"312","author":"A Zgonc \u0160kulj","year":"2020","unstructured":"Zgonc \u0160kulj A, Polj\u0161ak N, Ko\u010devar Glava\u010d N, Kreft S. Herbal preparations for the treatment of hair loss. Arch Dermatol Res. 2020;312:395\u2013406.","journal-title":"Arch Dermatol Res"},{"issue":"22","key":"4702_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.5530\/pj.2011.22.1","volume":"3","author":"RG Damodaran","year":"2011","unstructured":"Damodaran RG, Gupta R. Hair loss and the applied techniques for identification of novel hair growth promoters for hair re-growth. Pharmacogn J. 2011;3(22):1\u20135.","journal-title":"Pharmacogn J"},{"issue":"1","key":"4702_CR33","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.jaad.2017.04.1142","volume":"78","author":"LC Strazzulla","year":"2018","unstructured":"Strazzulla LC, Wang EHC, Avila L, Sicco KL, Brinster N, Christiano AM, et al. Alopecia areata: an appraisal of new treatment approaches and overview of current therapies. J Am Acad Dermatol. 2018;78(1):15\u201324.","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"4702_CR34","doi-asserted-by":"publisher","first-page":"2317","DOI":"10.1021\/acs.molpharmaceut.2c00796","volume":"20","author":"E Pena-Rodr\u00edguez","year":"2022","unstructured":"Pena-Rodr\u00edguez E, Garc\u00eda-Vega L, Lajarin Reinares M, Pastor-Anglada M, P\u00e9rez-Torras S, Fernandez-Campos F. Latanoprost-loaded Nanotransfersomes designed for scalp administration enhance keratinocytes proliferation. Mol Pharm. 2022;20(5):2317\u201325.","journal-title":"Mol Pharm"},{"issue":"3","key":"4702_CR35","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1111\/cen.15008","volume":"100","author":"TA de Oliveira","year":"2024","unstructured":"de Oliveira TA, Marchesan LB, Spritzer PM. Potassium levels in women with Polycystic Ovary Syndrome using spironolactone for long\u2010term. Clin Endocrinol Oxf. 2024;100(3):278\u201383.","journal-title":"Clin Endocrinol Oxf"},{"key":"4702_CR36","doi-asserted-by":"publisher","first-page":"53767","DOI":"10.12775\/QS.2024.17.53767","volume":"17","author":"OK Iszczuk","year":"2024","unstructured":"Iszczuk OK, Silldorff J, Fura T, Dudek M, Zaucha R, Gajkiewicz M, et al. Current state of knowledge about spironolactone-induded gynecomastia. Review 2024. Qual Sport. 2024;17:53767.","journal-title":"Qual Sport"},{"key":"4702_CR37","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.jdrv.2025.03.005","volume":"4","author":"SM Perez","year":"2025","unstructured":"Perez SM, Nguyen B, Senna MM. Efficacy and safety of bicalutamide in female hair loss: a review of the literature. JAAD Rev. 2025;4:61\u20138.","journal-title":"JAAD Rev"},{"key":"4702_CR38","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1007\/978-3-030-16928-2_28","volume-title":"Neurorheumatology: a comprehenisve guide to immune mediated disorders of the nervous system","author":"SY Lim","year":"2019","unstructured":"Lim SY, Bolster MB. Corticosteroids. In: Neurorheumatology: a comprehenisve guide to immune mediated disorders of the nervous system. Springer; 2019. p. 261\u20137."},{"key":"4702_CR39","doi-asserted-by":"publisher","first-page":"121273","DOI":"10.1016\/j.ijpharm.2021.121273","volume":"610","author":"C Costa","year":"2021","unstructured":"Costa C, Cavaco-Paulo A, Matam\u00e1 T. Mapping hair follicle-targeted delivery by particle systems: What has science accomplished so far? Int J Pharm. 2021;610:121273.","journal-title":"Int J Pharm"},{"issue":"1","key":"4702_CR40","first-page":"57","volume":"14","author":"ZSA Shaikh","year":"2023","unstructured":"Shaikh ZSA, Patel BAA, Patil SG, Maniyar ARS. Nanotechnology-based strategies for hair follicle regeneration in androgenetic alopecia. Mater Proc. 2023;14(1):57.","journal-title":"Mater Proc"},{"key":"4702_CR41","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.ejpb.2022.02.003","volume":"172","author":"PM Oliveira","year":"2022","unstructured":"Oliveira PM, Alencar-Silva T, Pires FQ, Cunha-Filho M, Gratieri T, Carvalho JL, et al. Nanostructured lipid carriers loaded with an association of minoxidil and latanoprost for targeted topical therapy of alopecia. Eur J Pharm Biopharm. 2022;172:78\u201388.","journal-title":"Eur J Pharm Biopharm"},{"key":"4702_CR42","first-page":"1231","volume":"9","author":"MJ Gomes","year":"2014","unstructured":"Gomes MJ, Martins S, Ferreira D, Segundo MA, Reis S. Lipid nanoparticles for topical and transdermal application for alopecia treatment: development, physicochemical characterization, and in vitro release and penetration studies. Int J Nanomedicine. 2014;9:1231\u201342.","journal-title":"Int J Nanomedicine"},{"issue":"2","key":"4702_CR43","doi-asserted-by":"publisher","first-page":"456","DOI":"10.3390\/ma17020456","volume":"17","author":"P Trucillo","year":"2024","unstructured":"Trucillo P. Biomaterials for drug delivery and human applications. Materials. 2024;17(2):456.","journal-title":"Materials"},{"key":"4702_CR44","doi-asserted-by":"publisher","first-page":"105890","DOI":"10.1016\/j.jddst.2024.105890","volume":"98","author":"TD Khairnar","year":"2024","unstructured":"Khairnar TD, Chavan GS, Sayyed MM, Gujarathi NA, Aher AA, Agrawal YO, et al. Recent trends in nanocarrier formulations of actives beyond minoxidil and 5-\u03b1 reductase inhibitors in androgenetic alopecia management: a systematic review. J Drug Deliv Sci Technol. 2024;98:105890.","journal-title":"J Drug Deliv Sci Technol"},{"issue":"3","key":"4702_CR45","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1080\/13543776.2020.1720649","volume":"30","author":"R Paliwal","year":"2020","unstructured":"Paliwal R, Paliwal SR, Kenwat R, Kurmi BD, Sahu MK. Solid lipid nanoparticles: a review on recent perspectives and patents. Expert Opin Ther Pat. 2020;30(3):179\u201394.","journal-title":"Expert Opin Ther Pat"},{"issue":"2","key":"4702_CR46","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1016\/j.ijpharm.2015.09.068","volume":"495","author":"H Wosicka-Fr\u0105ckowiak","year":"2015","unstructured":"Wosicka-Fr\u0105ckowiak H, Cal K, Stefanowska J, G\u0142\u00f3wka E, Nowacka M, Struck-Lewicka W, et al. Roxithromycin-loaded lipid nanoparticles for follicular targeting. Int J Pharm. 2015;495(2):807\u201315.","journal-title":"Int J Pharm"},{"issue":"6","key":"4702_CR47","doi-asserted-by":"publisher","first-page":"846","DOI":"10.3109\/03639045.2015.1062896","volume":"42","author":"H Hamishehkar","year":"2016","unstructured":"Hamishehkar H, Ghanbarzadeh S, Sepehran S, Javadzadeh Y, Adib ZM, Kouhsoltani M. Histological assessment of follicular delivery of flutamide by solid lipid nanoparticles: potential tool for the treatment of androgenic alopecia. Drug Dev Ind Pharm. 2016;42(6):846\u201353.","journal-title":"Drug Dev Ind Pharm"},{"issue":"3","key":"4702_CR48","doi-asserted-by":"publisher","first-page":"446","DOI":"10.34172\/apb.2023.056","volume":"13","author":"S Khan","year":"2023","unstructured":"Khan S, Sharma A, Jain V. An overview of nanostructured lipid carriers and its application in drug delivery through different routes. Adv Pharm Bull. 2023;13(3):446\u201360.","journal-title":"Adv Pharm Bull"},{"issue":"2","key":"4702_CR49","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1007\/s11095-012-0888-0","volume":"30","author":"YK Lin","year":"2013","unstructured":"Lin YK, Al-Suwayeh SA, Leu YL, Shen FM, Fang JY. Squalene-containing nanostructured lipid carriers promote percutaneous absorption and hair follicle targeting of diphencyprone for treating alopecia areata. Pharm Res. 2013;30(2):435\u201346.","journal-title":"Pharm Res"},{"key":"4702_CR50","doi-asserted-by":"publisher","DOI":"10.1007\/s00210-025-03784-x","author":"P Kushwaha","year":"2025","unstructured":"Kushwaha P, Usmani S, Sufiyan M, Singh P. Innovating alopecia treatment: Nanostructured lipid carriers as advanced delivery platforms. Naunyn-Schmiedebergs Arch Pharmacol. 2025. https:\/\/doi.org\/10.1007\/s00210-025-03784-x.","journal-title":"Naunyn-Schmiedebergs Arch Pharmacol"},{"issue":"2","key":"4702_CR51","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1208\/s12249-016-0519-x","volume":"18","author":"W Wang","year":"2017","unstructured":"Wang W, Chen L, Huang X, Shao A. Preparation and characterization of minoxidil loaded nanostructured lipid carriers. AAPS PharmSciTech. 2017;18(2):509\u201316.","journal-title":"AAPS PharmSciTech"},{"issue":"6","key":"4702_CR52","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1016\/j.nano.2015.04.009","volume":"11","author":"IA Aljuffali","year":"2015","unstructured":"Aljuffali IA, Pan TL, Sung CT, Chang SH, Fang JY. Anti-PDGF receptor \u03b2 antibody-conjugated squarticles loaded with minoxidil for alopecia treatment by targeting hair follicles and dermal papilla cells. Nanomedicine. 2015;11(6):1321\u201330.","journal-title":"Nanomedicine"},{"key":"4702_CR53","doi-asserted-by":"publisher","first-page":"5449","DOI":"10.2147\/IJN.S73010","volume":"9","author":"RN Shamma","year":"2014","unstructured":"Shamma RN, Aburahma MH. Follicular delivery of spironolactone via nanostructured lipid carriers for management of alopecia. Int J Nanomed. 2014;9:5449\u201360.","journal-title":"Int J Nanomed"},{"key":"4702_CR54","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1016\/j.jconrel.2024.06.060","volume":"372","author":"Q Li","year":"2024","unstructured":"Li Q, Wang Y, Guo Q, Cao J, Feng Y, Ke X. Nanostructured lipid carriers promote percutaneous absorption and hair follicle targeting of tofacitinib for treating alopecia areata. J Control Release. 2024;372:778\u201394.","journal-title":"J Control Release"},{"key":"4702_CR55","doi-asserted-by":"publisher","first-page":"231","DOI":"10.9734\/jpri\/2021\/v33i40A32239","volume":"33","author":"P Ananth","year":"2021","unstructured":"Ananth P, Koland M. Topical delivery of fenugreek seed extract loaded solid lipid nanoparticles based hydrogels for alopecia. J Pharm Res Int. 2021;33:231\u201341.","journal-title":"J Pharm Res Int"},{"issue":"1","key":"4702_CR56","doi-asserted-by":"publisher","first-page":"3022","DOI":"10.1080\/10717544.2022.2120927","volume":"29","author":"K Prabahar","year":"2022","unstructured":"Prabahar K, Udhumansha U, Elsherbiny N, Qushawy M. Microneedle mediated transdermal delivery of \u03b2-sitosterol loaded nanostructured lipid nanoparticles for androgenic alopecia. Drug Deliv. 2022;29(1):3022\u201334.","journal-title":"Drug Deliv"},{"issue":"6","key":"4702_CR57","doi-asserted-by":"publisher","first-page":"1671","DOI":"10.17576\/jsm-2023-5206-05","volume":"52","author":"H Hariyanti","year":"2023","unstructured":"Hariyanti H, Mauludin R, Sumirtapura YC, Kurniati NF. Activity and safety of cinchonine nanostructured lipid carriers as a hair growth stimulant in mice model of androgenetic alopecia. Sains Malaysiana. 2023;52(6):1671\u201383.","journal-title":"Sains Malaysiana"},{"issue":"1","key":"4702_CR58","first-page":"233","volume":"13","author":"S Daneshmand","year":"2023","unstructured":"Daneshmand S, Niazi M, Fazeli-Nasab B, Asili J, Golmohammadzadeh S, Sayyed R. Solid lipid nanoparticles of Platycladus orientalis L. possessing 5-alpha reductase inhibiting activity for treating hair loss and hirsutism. J Med Plants By-Prod. 2023;13(1):233\u201346.","journal-title":"J Med Plants By-Prod"},{"issue":"1","key":"4702_CR59","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1186\/1556-276X-8-102","volume":"8","author":"A Akbarzadeh","year":"2013","unstructured":"Akbarzadeh A, Rezaei-Sadabady R, Davaran S, Joo SW, Zarghami N, Hanifehpour Y, et al. Liposome: classification, preparation, and applications. Nanoscale Res Lett. 2013;8(1):102.","journal-title":"Nanoscale Res Lett"},{"key":"4702_CR60","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1080\/08982104.2024.2377085","volume":"34","author":"MM AbouSamra","year":"2024","unstructured":"AbouSamra MM. Liposomal nano-carriers mediated targeting of liver disorders: mechanisms and applications. J Liposome Res. 2024;34:728\u201343.","journal-title":"J Liposome Res"},{"issue":"3","key":"4702_CR61","doi-asserted-by":"publisher","first-page":"e65815","DOI":"10.5812\/jssc.65815","volume":"3","author":"HR Ahmadi Ashtiani","year":"2016","unstructured":"Ahmadi Ashtiani HR, Bishe P, Lashgari N, Nilforoushzadeh MA, Zare S. Liposomes in cosmetics. J Skin Stem Cell. 2016;3(3):e65815.","journal-title":"J Skin Stem Cell"},{"key":"4702_CR62","doi-asserted-by":"publisher","first-page":"102757","DOI":"10.1016\/j.cis.2022.102757","volume":"309","author":"M Dymek","year":"2022","unstructured":"Dymek M, Sikora E. Liposomes as biocompatible and smart delivery systems\u2014the current state. Adv Colloid Interface Sci. 2022;309:102757.","journal-title":"Adv Colloid Interface Sci"},{"issue":"4","key":"4702_CR63","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.ejps.2011.04.003","volume":"43","author":"B Geusens","year":"2011","unstructured":"Geusens B, Strobbe T, Bracke S, Dynoodt P, Sanders N, Van Gele M, et al. Lipid-mediated gene delivery to the skin. Eur J Pharm Sci. 2011;43(4):199\u2013211.","journal-title":"Eur J Pharm Sci"},{"issue":"7","key":"4702_CR64","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1517\/17425247.5.7.737","volume":"5","author":"D Cosco","year":"2008","unstructured":"Cosco D, Celia C, Cilurzo F, Trapasso E, Paolino D. Colloidal carriers for the enhanced delivery through the skin. Expert Opin Drug Deliv. 2008;5(7):737\u201355.","journal-title":"Expert Opin Drug Deliv"},{"key":"4702_CR65","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.jddst.2018.09.006","volume":"48","author":"H-L Xu","year":"2018","unstructured":"Xu H-L, Chen P-P, Wang L-f, Xue W, Fu T-L. Hair regenerative effect of silk fibroin hydrogel with incorporation of FGF-2-liposome and its potential mechanism in mice with testosterone-induced alopecia areata. J Drug Deliv Sci Technol. 2018;48:128\u201336.","journal-title":"J Drug Deliv Sci Technol"},{"key":"4702_CR66","doi-asserted-by":"publisher","first-page":"1709","DOI":"10.1007\/s40279-017-0698-y","volume":"47","author":"D Hooper","year":"2017","unstructured":"Hooper D, Kraemer W, Focht B, Volek J, DuPont W, Caldwell L, et al. Endocrinological roles for testosterone in resistance exercise responses and adaptations. Sports Med. 2017;47:1709\u201320.","journal-title":"Sports Med"},{"issue":"15","key":"4702_CR67","doi-asserted-by":"publisher","first-page":"5342","DOI":"10.3390\/ijms21155342","volume":"21","author":"M Grymowicz","year":"2020","unstructured":"Grymowicz M, Rudnicka E, Podfigurna A, Napierala P, Smolarczyk R, Smolarczyk K, et al. Hormonal effects on hair follicles. Int J Mol Sci. 2020;21(15):5342.","journal-title":"Int J Mol Sci"},{"issue":"10","key":"4702_CR68","doi-asserted-by":"publisher","first-page":"9498","DOI":"10.1007\/s12274-022-4710-y","volume":"15","author":"X Zhang","year":"2022","unstructured":"Zhang X, Li S, Dong Y, Rong H, Zhao J, Hu H. A multifunctional cholesterol-free liposomal platform based on protopanaxadiol for alopecia therapy. Nano Res. 2022;15(10):9498\u2013510.","journal-title":"Nano Res"},{"key":"4702_CR69","first-page":"190","volume":"32","author":"H Xing","year":"2024","unstructured":"Xing H, Peng H, Yang Y, Lv K, Zhou S, Pan X, et al. Nitric oxide synergizes minoxidil delivered by transdermal hyaluronic acid liposomes for multimodal androgenetic-alopecia therapy. Bioact Mater. 2024;32:190\u2013205.","journal-title":"Bioact Mater"},{"issue":"3","key":"4702_CR70","doi-asserted-by":"publisher","first-page":"138","DOI":"10.4103\/2231-4040.85524","volume":"2","author":"R Rajan","year":"2011","unstructured":"Rajan R, Jose S, Mukund VP, Vasudevan DT. Transfersomes\u2014a vesicular transdermal delivery system for enhanced drug permeation. J Adv Pharm Technol Res. 2011;2(3):138\u201343.","journal-title":"J Adv Pharm Technol Res"},{"issue":"2","key":"4702_CR71","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/S0005-2736(01)00369-8","volume":"1514","author":"G Cevc","year":"2001","unstructured":"Cevc G, Blume G. New, highly efficient formulation of diclofenac for the topical, transdermal administration in ultradeformable drug carriers, Transfersomes. Biochimica et Biophysica Acta (BBA). 2001;1514(2):191\u2013205.","journal-title":"Biochimica et Biophysica Acta (BBA)"},{"key":"4702_CR72","doi-asserted-by":"publisher","first-page":"119500","DOI":"10.1016\/j.ijpharm.2020.119500","volume":"585","author":"ZJ Zhang","year":"2020","unstructured":"Zhang ZJ, Michniak-Kohn B. Flavosomes, novel deformable liposomes for the co-delivery of anti-inflammatory compounds to skin. Int J Pharm. 2020;585:119500.","journal-title":"Int J Pharm"},{"issue":"9","key":"4702_CR73","doi-asserted-by":"publisher","first-page":"855","DOI":"10.3390\/pharmaceutics12090855","volume":"12","author":"SAT Opatha","year":"2020","unstructured":"Opatha SAT, Titapiwatanakun V, Chutoprapat R. Transfersomes: a promising nanoencapsulation technique for transdermal drug delivery. Pharmaceutics. 2020;12(9):855.","journal-title":"Pharmaceutics"},{"issue":"1","key":"4702_CR74","doi-asserted-by":"publisher","first-page":"1325708","DOI":"10.1080\/20022727.2017.1325708","volume":"8","author":"S Rai","year":"2017","unstructured":"Rai S, Pandey V, Rai G. Transfersomes as versatile and flexible nano-vesicular carriers in skin cancer therapy: the state of the art. Nano Rev Exp. 2017;8(1):1325708.","journal-title":"Nano Rev Exp"},{"key":"4702_CR75","doi-asserted-by":"publisher","first-page":"2259","DOI":"10.2147\/DDDT.S171888","volume":"12","author":"OA Ahmed","year":"2018","unstructured":"Ahmed OA, Rizq WY. Finasteride nano-transferosomal gel formula for management of androgenetic alopecia: ex vivo investigational approach. Drug Des Devel Ther. 2018;12:2259\u201365.","journal-title":"Drug Des Devel Ther"},{"key":"4702_CR76","doi-asserted-by":"publisher","first-page":"123498","DOI":"10.1016\/j.ijpharm.2023.123498","volume":"646","author":"A Yan","year":"2023","unstructured":"Yan A, Ruan R, Zhu X, Qiang W, Guan Y, Yu Q, et al. Co-delivery of minoxidil and tocopherol acetate ethosomes to reshape the hair follicular microenvironment and promote hair regeneration in androgenetic alopecia. Int J Pharm. 2023;646:123498.","journal-title":"Int J Pharm"},{"key":"4702_CR77","doi-asserted-by":"publisher","first-page":"123963","DOI":"10.1016\/j.ijpharm.2024.123963","volume":"654","author":"X Liu","year":"2024","unstructured":"Liu X, Kong X, Xu L, Su Y, Xu S, Pang X, et al. Synergistic therapeutic effect of ginsenoside Rg3 modified minoxidil transfersomes (MXD-Rg3@TFs) on androgenic alopecia in C57BL\/6 mice. Int J Pharm. 2024;654:123963.","journal-title":"Int J Pharm"},{"key":"4702_CR78","doi-asserted-by":"publisher","first-page":"104725","DOI":"10.1016\/j.jddst.2023.104725","volume":"86","author":"X Liu","year":"2023","unstructured":"Liu X, Guo F, Liang D, Li Z, Cao Y, Chen M, et al. Development and evaluation of finasteride niosomes targeting to hair follicles for the management of androgenic alopecia. J Drug Deliv Sci Technol. 2023;86:104725.","journal-title":"J Drug Deliv Sci Technol"},{"key":"4702_CR79","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics13122177","author":"W Rungseevijitprapa","year":"2021","unstructured":"Rungseevijitprapa W, Wichayapreechar P, Sivamaruthi BS, Jinarat D, Chaiyasut C. Optimization and transfollicular delivery of finasteride-loaded proniosomes for hair growth stimulation in C57BL\/6Mlac mice. Pharmaceutics. 2021. https:\/\/doi.org\/10.3390\/pharmaceutics13122177.","journal-title":"Pharmaceutics"},{"key":"4702_CR80","doi-asserted-by":"publisher","first-page":"2367","DOI":"10.52711\/0974-360X.2021.00418","volume":"14","author":"D Rani","year":"2021","unstructured":"Rani D, Sharma V, Manchanda R, Chaurasia H. Formulation, design and optimization of glycerosomes for topical delivery of minoxidil. Res J Pharm Technol. 2021;14:2367\u201374.","journal-title":"Res J Pharm Technol"},{"key":"4702_CR81","doi-asserted-by":"publisher","first-page":"103790","DOI":"10.1016\/j.jddst.2022.103790","volume":"76","author":"AA Allam","year":"2022","unstructured":"Allam AA, Fathalla D, Safwat MA, Soliman GM. Transferosomes versus transethosomes for the dermal delivery for minoxidil: preparation and in vitro\/ex vivo appraisal. J Drug Deliv Sci Technol. 2022;76:103790.","journal-title":"J Drug Deliv Sci Technol"},{"key":"4702_CR82","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.jconrel.2020.06.019","volume":"325","author":"S Salim","year":"2020","unstructured":"Salim S, Kamalasanan K. Controlled drug delivery for alopecia: a review. J Control Release. 2020;325:84\u201399.","journal-title":"J Control Release"},{"issue":"2","key":"4702_CR83","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1007\/s13205-014-0214-0","volume":"5","author":"M Jaiswal","year":"2015","unstructured":"Jaiswal M, Dudhe R, Sharma PK. Nanoemulsion: an advanced mode of drug delivery system. 3 Biotech. 2015;5(2):123\u20137.","journal-title":"3 Biotech"},{"key":"4702_CR84","doi-asserted-by":"publisher","first-page":"6640103","DOI":"10.1155\/2023\/6640103","volume":"2023","author":"A Preeti","year":"2023","unstructured":"Preeti A, Sambhakar S, Malik R, Bhatia S, Al Harrasi A, Rani C, et al. Nanoemulsion: an emerging novel technology for improving the bioavailability of drugs. Scientifica. 2023;2023:6640103.","journal-title":"Scientifica"},{"key":"4702_CR85","doi-asserted-by":"publisher","first-page":"100684","DOI":"10.1016\/j.fochx.2023.100684","volume":"18","author":"A Mushtaq","year":"2023","unstructured":"Mushtaq A, Mohd Wani S, Malik AR, Gull A, Ramniwas S, Ahmad Nayik G, et al. Recent insights into nanoemulsions: their preparation, properties and applications. Food Chem X. 2023;18:100684.","journal-title":"Food Chem X"},{"key":"4702_CR86","doi-asserted-by":"publisher","first-page":"101908","DOI":"10.1016\/j.jddst.2020.101908","volume":"59","author":"SA Cardoso","year":"2020","unstructured":"Cardoso SA, Barradas TN. Developing formulations for drug follicular targeting: nanoemulsions loaded with minoxidil and clove oil. J Drug Deliv Sci Technol. 2020;59:101908.","journal-title":"J Drug Deliv Sci Technol"},{"issue":"8","key":"4702_CR87","doi-asserted-by":"publisher","first-page":"1721","DOI":"10.1007\/s13555-023-00974-4","volume":"13","author":"M Escamilla-Cruz","year":"2023","unstructured":"Escamilla-Cruz M, Maga\u00f1a M, Escand\u00f3n-Perez S, Bello-Chavolla OY. Use of 5-alpha reductase inhibitors in dermatology: a narrative review. Dermatol Therapy. 2023;13(8):1721\u201331.","journal-title":"Dermatol Therapy"},{"issue":"1","key":"4702_CR88","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1049\/nbt2.12101","volume":"17","author":"M Memar Bashi Aval","year":"2023","unstructured":"Memar Bashi Aval M, Hoveizi E, Mombeiny R, Kazemi M, Saeedi S, Tavakol S. Dutasteride nanoemulsion preparation to inhibit 5-alpha-hair follicle reductase enzymes in the hair follicle; an ex vivo study. IET Nanobiotechnol. 2023;17(1):13\u201321.","journal-title":"IET Nanobiotechnol"},{"key":"4702_CR89","doi-asserted-by":"publisher","first-page":"123121","DOI":"10.1016\/j.ijpharm.2023.123121","volume":"642","author":"S Palakkal","year":"2023","unstructured":"Palakkal S, Cortial A, Fru\u0161i\u0107-Zlotkin M, Soroka Y, Tzur T, Nassar T, et al. Effect of cyclosporine A\u2014tempol topical gel for the treatment of alopecia and anti-inflammatory disorders. Int J Pharm. 2023;642:123121.","journal-title":"Int J Pharm"},{"key":"4702_CR90","doi-asserted-by":"publisher","first-page":"107502","DOI":"10.1016\/j.jddst.2025.107502","volume":"114","author":"A Maged","year":"2025","unstructured":"Maged A, Kamel R, Mahmoud AA, Elkhawas YA, Mohamed SK, Khalil N. Sildenafil-chitosan nanocomplexes in rosemary-infused smart emulgel: sustainable drug delivery with improved hair regeneration efficacy. J Drug Deliv Sci Technol. 2025;114:107502.","journal-title":"J Drug Deliv Sci Technol"},{"key":"4702_CR91","doi-asserted-by":"publisher","first-page":"107413","DOI":"10.1016\/j.ejps.2025.107413","volume":"217","author":"N Erdo\u011far","year":"2026","unstructured":"Erdo\u011far N, G\u00fcr B, \u00d6rg\u00fcl D. Recent developments of novel nanotechnology-based drug delivery systems for dermal and transdermal applications. Eur J Pharm Sci. 2026;217:107413.","journal-title":"Eur J Pharm Sci"},{"issue":"4","key":"4702_CR92","doi-asserted-by":"publisher","first-page":"4354","DOI":"10.1021\/acsnano.8b09573","volume":"13","author":"G Yang","year":"2019","unstructured":"Yang G, Chen Q, Wen D, Chen Z, Wang J, Chen G, et al. A Therapeutic microneedle patch made from hair-derived keratin for promoting hair regrowth. ACS Nano. 2019;13(4):4354\u201360.","journal-title":"ACS Nano"},{"issue":"3","key":"4702_CR93","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1016\/j.jaad.2020.06.1009","volume":"84","author":"M Randolph","year":"2021","unstructured":"Randolph M, Tosti A. Oral minoxidil treatment for hair loss: a review of efficacy and safety. J Am Acad Dermatol. 2021;84(3):737\u201346.","journal-title":"J Am Acad Dermatol"},{"issue":"Suppl 2","key":"4702_CR94","doi-asserted-by":"publisher","first-page":"S225","DOI":"10.1542\/peds.2019-2056L","volume":"145","author":"KA Habeshian","year":"2020","unstructured":"Habeshian KA, Cohen BA. Current issues in the treatment of acne vulgaris. Pediatrics. 2020;145(Suppl 2):S225\u201330.","journal-title":"Pediatrics"},{"issue":"2","key":"4702_CR95","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1016\/j.xphs.2020.10.060","volume":"110","author":"V Garg","year":"2021","unstructured":"Garg V, Nirmal J, Riadi Y, Kesharwani P, Kohli K, Jain GK. Amelioration of endotoxin-induced uveitis in rabbit by topical administration of tacrolimus Proglycosome nano-vesicles. J Pharm Sci. 2021;110(2):871\u20135.","journal-title":"J Pharm Sci"},{"key":"4702_CR96","doi-asserted-by":"publisher","first-page":"112050","DOI":"10.1016\/j.colsurfb.2021.112050","volume":"208","author":"P Mishra","year":"2021","unstructured":"Mishra P, Handa M, Ujjwal RR, Singh V, Kesharwani P, Shukla R. Potential of nanoparticulate based delivery systems for effective management of alopecia. Colloids Surf B Biointerfaces. 2021;208:112050.","journal-title":"Colloids Surf B Biointerfaces"},{"issue":"1\u20132","key":"4702_CR97","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/j.ijpharm.2008.10.003","volume":"366","author":"J Pardeike","year":"2009","unstructured":"Pardeike J, Hommoss A, M\u00fcller RH. Lipid nanoparticles (SLN, NLC) in cosmetic and pharmaceutical dermal products. Int J Pharm. 2009;366(1\u20132):170\u201384.","journal-title":"Int J Pharm"},{"issue":"1-2","key":"4702_CR98","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/j.ijpharm.2010.03.049","volume":"392","author":"TK Kwon","year":"2010","unstructured":"Kwon TK, Kim JC. In vitro skin permeation of monoolein nanoparticles containing hydroxypropyl beta-cyclodextrin\/minoxidil complex. Int J Pharm. 2010;392(1\u20132):268\u201373.","journal-title":"Int J Pharm"},{"issue":"3","key":"4702_CR99","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1111\/j.1468-2494.2008.00433.x","volume":"30","author":"EB Souto","year":"2008","unstructured":"Souto EB, M\u00fcller RH. Cosmetic features and applications of lipid nanoparticles (SLN, NLC). Int J Cosmet Sci. 2008;30(3):157\u201365.","journal-title":"Int J Cosmet Sci"},{"issue":"1","key":"4702_CR100","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.colsurfb.2010.07.020","volume":"81","author":"AP Nayak","year":"2010","unstructured":"Nayak AP, Tiyaboonchai W, Patankar S, Madhusudhan B, Souto EB. Curcuminoids-loaded lipid nanoparticles: novel approach towards malaria treatment. Colloids Surf B Biointerfaces. 2010;81(1):263\u201373.","journal-title":"Colloids Surf B Biointerfaces"},{"issue":"2","key":"4702_CR101","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/S0169-409X(01)00105-3","volume":"47","author":"W Mehnert","year":"2001","unstructured":"Mehnert W, M\u00e4der K. Solid lipid nanoparticles: production, characterization and applications. Adv Drug Deliv Rev. 2001;47(2):165\u201396.","journal-title":"Adv Drug Deliv Rev"},{"issue":"1","key":"4702_CR102","first-page":"380","volume":"8","author":"MM AbouSamra","year":"2016","unstructured":"AbouSamra MM, Mohsen AM. Solid lipid nanoparticles and nanostructured lipid carriers of tolnaftate: design, optimization and in-vitro evaluation. Int J Pharm Pharm Sci. 2016;8(1):380\u20135.","journal-title":"Int J Pharm Pharm Sci"},{"key":"4702_CR103","doi-asserted-by":"publisher","first-page":"103176","DOI":"10.1016\/j.jddst.2022.103176","volume":"69","author":"VGS Jyothi","year":"2022","unstructured":"Jyothi VGS, Ghouse SM, Khatri DK, Nanduri S, Singh SB, Madan J. Lipid nanoparticles in topical dermal drug delivery: Does chemistry of lipid persuade skin penetration? J Drug Deliv Sci Technol. 2022;69:103176.","journal-title":"J Drug Deliv Sci Technol"},{"key":"4702_CR104","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics13040549","author":"SS Hallan","year":"2021","unstructured":"Hallan SS, Sguizzato M, Esposito E, Cortesi R. Challenges in the physical characterization of lipid nanoparticles. Pharmaceutics. 2021. https:\/\/doi.org\/10.3390\/pharmaceutics13040549.","journal-title":"Pharmaceutics"},{"issue":"1","key":"4702_CR105","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/S0939-6411(03)00040-7","volume":"56","author":"SA Wissing","year":"2003","unstructured":"Wissing SA, M\u00fcller RH. The influence of solid lipid nanoparticles on skin hydration and viscoelasticity\u2014in vivo study. Eur J Pharm Biopharm. 2003;56(1):67\u201372.","journal-title":"Eur J Pharm Biopharm"},{"issue":"2","key":"4702_CR106","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1080\/17425247.2017.1264386","volume":"14","author":"R Arora","year":"2017","unstructured":"Arora R, Katiyar SS, Kushwah V, Jain S. Solid lipid nanoparticles and nanostructured lipid carrier-based nanotherapeutics in treatment of psoriasis: a comparative study. Expert Opin Drug Deliv. 2017;14(2):165\u201377.","journal-title":"Expert Opin Drug Deliv"},{"key":"4702_CR107","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.ejps.2017.11.023","volume":"112","author":"A Garc\u00eas","year":"2018","unstructured":"Garc\u00eas A, Amaral MH, Sousa Lobo JM, Silva AC. Formulations based on solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) for cutaneous use: a review. Eur J Pharm Sci. 2018;112:159\u201367.","journal-title":"Eur J Pharm Sci"},{"issue":"2","key":"4702_CR108","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.ejpb.2006.10.019","volume":"66","author":"J Lademann","year":"2007","unstructured":"Lademann J, Richter H, Teichmann A, Otberg N, Blume-Peytavi U, Luengo J, et al. Nanoparticles--an efficient carrier for drug delivery into the hair follicles. Eur J Pharm Biopharm. 2007;66(2):159\u201364.","journal-title":"Eur J Pharm Biopharm"},{"issue":"3","key":"4702_CR109","doi-asserted-by":"publisher","first-page":"772","DOI":"10.3390\/pharmaceutics15030772","volume":"15","author":"Y Seo","year":"2023","unstructured":"Seo Y, Lim H, Park H, Yu J, An J, Yoo HY, et al. Recent progress of lipid nanoparticles-based lipophilic drug delivery: focus on surface modifications. Pharmaceutics. 2023;15(3):772.","journal-title":"Pharmaceutics"},{"key":"4702_CR110","first-page":"1767","volume-title":"Towards rational design of multifunctional theranostic nanoparticles: What barriers do we need to overcome?","author":"BB Rajeeva","year":"2014","unstructured":"Rajeeva BB, Menz R, Zheng Y. Towards rational design of multifunctional theranostic nanoparticles: What barriers do we need to overcome? Taylor & Francis; 2014. p. 1767\u201370."},{"issue":"6","key":"4702_CR111","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1615\/CritRevTherDrugCarrierSyst.v26.i6.10","volume":"26","author":"A Puri","year":"2009","unstructured":"Puri A, Loomis K, Smith B, Lee JH, Yavlovich A, Heldman E, et al. Lipid-based nanoparticles as pharmaceutical drug carriers: from concepts to clinic. Crit Rev Ther Drug Carrier Syst. 2009;26(6):523\u201380.","journal-title":"Crit Rev Ther Drug Carrier Syst"},{"issue":"6","key":"4702_CR112","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1021\/acsmaterialsau.3c00032","volume":"3","author":"M Mehta","year":"2023","unstructured":"Mehta M, Bui TA, Yang X, Aksoy Y, Goldys EM, Deng W. Lipid-based nanoparticles for drug\/gene delivery: an overview of the production techniques and difficulties encountered in their industrial development. ACS Mater Au. 2023;3(6):600\u201319.","journal-title":"ACS Mater Au"},{"key":"4702_CR113","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.jcis.2017.05.038","volume":"504","author":"T Chantaburanan","year":"2017","unstructured":"Chantaburanan T, Teeranachaideekul V, Chantasart D, Jintapattanakit A, Junyaprasert VB. Effect of binary solid lipid matrix of wax and triglyceride on lipid crystallinity, drug-lipid interaction and drug release of ibuprofen-loaded solid lipid nanoparticles (SLN) for dermal delivery. J Colloid Interface Sci. 2017;504:247\u201356.","journal-title":"J Colloid Interface Sci"},{"key":"4702_CR114","doi-asserted-by":"publisher","DOI":"10.3390\/ijms242115764","author":"R Ashfaq","year":"2023","unstructured":"Ashfaq R, Rasul A, Asghar S, Kov\u00e1cs A, Berk\u00f3 S, Budai-Sz\u0171cs M. Lipid nanoparticles: an effective tool to improve the bioavailability of nutraceuticals. Int J Mol Sci. 2023. https:\/\/doi.org\/10.3390\/ijms242115764.","journal-title":"Int J Mol Sci"},{"key":"4702_CR115","doi-asserted-by":"publisher","first-page":"100353","DOI":"10.1016\/j.microb.2025.100353","volume":"7","author":"JK Paul","year":"2025","unstructured":"Paul JK, Azmal M, Talukder OF, Haque ANMSNB, Meem M, Ghosh A. Unlocking the secrets of the hair microbiome: from scalp health to therapeutic advances. Microbe. 2025;7:100353.","journal-title":"Microbe"},{"issue":"2","key":"4702_CR116","doi-asserted-by":"publisher","first-page":"2100109","DOI":"10.1002\/anbr.202100109","volume":"2","author":"L Xu","year":"2022","unstructured":"Xu L, Wang X, Liu Y, Yang G, Falconer RJ, Zhao C-X. Lipid nanoparticles for drug delivery. Adv NanoBiomed Res. 2022;2(2):2100109.","journal-title":"Adv NanoBiomed Res"},{"key":"4702_CR117","doi-asserted-by":"publisher","DOI":"10.55940\/medphar2025118","author":"SR Vikhe","year":"2025","unstructured":"Vikhe SR, Pathade PM, Tambe BR. Stimuli-responsive nanocarriers: revolutionizing site-specific drug release. Med Pharm J. 2025. https:\/\/doi.org\/10.55940\/medphar2025118.","journal-title":"Med Pharm J"},{"issue":"10","key":"4702_CR118","doi-asserted-by":"publisher","first-page":"2749","DOI":"10.1007\/s13555-025-01517-9","volume":"15","author":"K Sanchez","year":"2025","unstructured":"Sanchez K, Englander H, Salloum L, Gregoire S, Biba U, Ershadi S, et al. Evaluating current and emergent JAK inhibitors for alopecia areata: a narrative review. Dermatol Ther (Heidelb). 2025;15(10):2749\u201364.","journal-title":"Dermatol Ther (Heidelb)"},{"issue":"1","key":"4702_CR119","doi-asserted-by":"publisher","first-page":"3","DOI":"10.4103\/ijt.ijt_28_21","volume":"15","author":"K Malhotra","year":"2023","unstructured":"Malhotra K, Madke B. An updated review on current treatment of alopecia areata and newer therapeutic options. Int J Trichology. 2023;15(1):3\u201312.","journal-title":"Int J Trichology"},{"issue":"1","key":"4702_CR120","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1186\/s12951-025-03407-w","volume":"23","author":"L Zheng","year":"2025","unstructured":"Zheng L, Du Y, Zhang L, Jin F, Li W, Zhou X, et al. Enhanced therapeutic effects of all-trans retinoic acid nanostructured lipid carrier composite gel drug delivery system for alopecia areata. J Nanobiotechnol. 2025;23(1):351.","journal-title":"J Nanobiotechnol"},{"key":"4702_CR121","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26083461","author":"J Kim","year":"2025","unstructured":"Kim J, Song SY, Sung JH. Recent advances in drug development for hair loss. Int J Mol Sci. 2025. https:\/\/doi.org\/10.3390\/ijms26083461.","journal-title":"Int J Mol Sci"},{"issue":"10","key":"4702_CR122","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1080\/17425247.2018.1517740","volume":"15","author":"S Hatem","year":"2018","unstructured":"Hatem S, Nasr M, Moftah NH, Ragai MH, Geneidi AS, Elkheshen SA. Clinical cosmeceutical repurposing of melatonin in androgenic alopecia using nanostructured lipid carriers prepared with antioxidant oils. Expert Opin Drug Deliv. 2018;15(10):927\u201335.","journal-title":"Expert Opin Drug Deliv"},{"issue":"10","key":"4702_CR123","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.1080\/17425247.2021.1936497","volume":"18","author":"GM El-Zaafarany","year":"2021","unstructured":"El-Zaafarany GM, Abdel-Aziz RT, Montaser MHA, Nasr M. Coenzyme Q10 phospholipidic vesicular formulations for treatment of androgenic alopecia: ex vivo permeation and clinical appraisal. Expert Opin Drug Deliv. 2021;18(10):1513\u201322.","journal-title":"Expert Opin Drug Deliv"},{"key":"4702_CR124","unstructured":"\u30e6, \u30ad\u30e7\u30f3\u30ca\u30e0, inventor. Nanoliposomes-microbubble conjugates containing therapeutic agents for hair loss 2021."},{"key":"4702_CR125","unstructured":"Victor H, Mauro C, inventors. Topical formulations comprising dutasteride for treating dermatological disorders including male pattern baldness, 2021."},{"key":"4702_CR126","unstructured":"Nanotechnology drug delivery market: a deep-dive analysis [Internet]. 2025."},{"issue":"5","key":"4702_CR127","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1208\/s12249-025-03157-w","volume":"26","author":"R Kamel","year":"2025","unstructured":"Kamel R, Nocca G, Mazzinelli E, Abd El-Karim SS, Papa V, Cacciotti I, et al. Unveiling the potential of nanoclays in pharmaceuticals. AAPS PharmSciTech. 2025;26(5):167.","journal-title":"AAPS PharmSciTech"},{"key":"4702_CR128","doi-asserted-by":"publisher","first-page":"1544393","DOI":"10.3389\/fmed.2025.1544393","volume":"12","author":"FD Rodr\u00edguez-G\u00f3mez","year":"2025","unstructured":"Rodr\u00edguez-G\u00f3mez FD, Monferrer D, Penon O, Rivera-Gil P. Regulatory pathways and guidelines for nanotechnology-enabled health products: a comparative review of EU and US frameworks. Front Med. 2025;12:1544393.","journal-title":"Front Med"},{"key":"4702_CR129","doi-asserted-by":"publisher","first-page":"1125577","DOI":"10.3389\/fpubh.2023.1125577","volume":"11","author":"W Oualikene-Gonin","year":"2023","unstructured":"Oualikene-Gonin W, Sautou V, Ezan E, Bastos H, Bellissant E, Belgod\u00e8re L, et al. Regulatory assessment of nano-enabled health products in public health interest. Position of the scientific advisory board of the French National Agency for the Safety of Medicines and Health Products. Front Public Health. 2023;11:1125577.","journal-title":"Front Public Health"},{"issue":"6","key":"4702_CR130","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1038\/nnano.2017.67","volume":"12","author":"SR D\u2019Mello","year":"2017","unstructured":"D\u2019Mello SR, Cruz CN, Chen ML, Kapoor M, Lee SL, Tyner KM. The evolving landscape of drug products containing nanomaterials in the United States. Nat Nanotechnol. 2017;12(6):523\u20139.","journal-title":"Nat Nanotechnol"},{"issue":"7","key":"4702_CR131","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1038\/nmat2442","volume":"8","author":"AE Nel","year":"2009","unstructured":"Nel AE, M\u00e4dler L, Velegol D, Xia T, Hoek EM, Somasundaran P, et al. Understanding biophysicochemical interactions at the nano\u2013bio interface. Nat Mater. 2009;8(7):543\u201357.","journal-title":"Nat Mater"},{"key":"4702_CR132","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1007\/978-3-031-12398-6_19","volume-title":"Recent advances in therapeutic drug monitoring and clinical toxicology","author":"A Panghal","year":"2022","unstructured":"Panghal A, Flora SJS. Toxicity evaluation of nanomedicine. In: Recent advances in therapeutic drug monitoring and clinical toxicology. Springer; 2022. p. 323\u201345."},{"issue":"1","key":"4702_CR133","doi-asserted-by":"publisher","first-page":"3","DOI":"10.2174\/2211738505666171023152928","volume":"6","author":"MA Saifi","year":"2018","unstructured":"Saifi MA, Khan W, Godugu C. Cytotoxicity of nanomaterials: using nanotoxicology to address the safety concerns of nanoparticles. Pharm Nanotechnol. 2018;6(1):3\u201316.","journal-title":"Pharm Nanotechnol"},{"issue":"1","key":"4702_CR134","doi-asserted-by":"publisher","first-page":"10435","DOI":"10.1038\/s41598-020-67349-z","volume":"10","author":"DA Abdel Fadeel","year":"2020","unstructured":"Abdel Fadeel DA, Kamel R, Fadel M. PEGylated lipid nanocarrier for enhancing photodynamic therapy of skin carcinoma using curcumin: in-vitro\/in-vivo studies and histopathological examination. Sci Rep. 2020;10(1):10435.","journal-title":"Sci Rep"},{"issue":"5","key":"4702_CR135","doi-asserted-by":"publisher","first-page":"990","DOI":"10.3109\/10837450.2011.609992","volume":"18","author":"R Kamel","year":"2013","unstructured":"Kamel R, Abbas H. Self-assembled carbohydrate hydrogels for prolonged pain management. Pharm Dev Technol. 2013;18(5):990\u20131004.","journal-title":"Pharm Dev Technol"},{"issue":"1\u20132","key":"4702_CR136","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.ijpharm.2005.07.014","volume":"305","author":"J Hadgraft","year":"2005","unstructured":"Hadgraft J, Lane ME. Skin permeation: the years of enlightenment. Int J Pharm. 2005;305(1\u20132):2\u201312.","journal-title":"Int J Pharm"},{"issue":"9","key":"4702_CR137","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1007\/s00420-009-0458-x","volume":"82","author":"M Crosera","year":"2009","unstructured":"Crosera M, Bovenzi M, Maina G, Adami G, Zanette C, Florio C, et al. Nanoparticle dermal absorption and toxicity: a review of the literature. Int Arch Occup Environ Health. 2009;82(9):1043\u201355.","journal-title":"Int Arch Occup Environ Health"},{"issue":"1\u20132","key":"4702_CR138","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/j.ijpharm.2008.01.045","volume":"357","author":"C Puglia","year":"2008","unstructured":"Puglia C, Blasi P, Rizza L, Schoubben A, Bonina F, Rossi C, et al. Lipid nanoparticles for prolonged topical delivery: an in vitro and in vivo investigation. Int J Pharm. 2008;357(1\u20132):295\u2013304.","journal-title":"Int J Pharm"},{"key":"4702_CR139","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1016\/B978-0-12-813629-4.00016-4","volume-title":"Nanoscale fabrication, optimization, scale-up and biological aspects of pharmaceutical nanotechnology","author":"Z Rahman","year":"2018","unstructured":"Rahman Z, Charoo NA, Akhter S, Beg S, Reddy IK, Khan MA. Nanotechnology-based drug products: science and regulatory considerations. In: Nanoscale fabrication, optimization, scale-up and biological aspects of pharmaceutical nanotechnology. Elsevier; 2018. p. 619\u201355."}],"container-title":["Discover Nano"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s11671-026-04702-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s11671-026-04702-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s11671-026-04702-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:20:49Z","timestamp":1782865249000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s11671-026-04702-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,30]]},"references-count":139,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4702"],"URL":"https:\/\/doi.org\/10.1186\/s11671-026-04702-7","relation":{},"ISSN":["2731-9229"],"issn-type":[{"value":"2731-9229","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,30]]},"assertion":[{"value":"15 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"AI-assisted technologies were only used to improve the readability and language of the manuscript. After use, the authors reviewed and edited the content as needed and take full responsibility for the content of the published article.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declaration of AI-assisted technologies in the writing process"}}],"article-number":"310"}}